Aurora Spine to Attend the American Academy of Orthopaedic Surgeons Annual Meeting
Aurora Spine (OTCQB: ASAPF) has announced its participation in the 2025 American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting from March 10-14, 2025, at the San Diego Convention Center – Booth #1847.
At the world's largest gathering of orthopedic professionals, Aurora Spine will showcase its innovative product line, including:
- DEXA-C™: A cervical cage for ACDF procedures featuring patented DEXA Technology™ that matches implant density to patient's bone density
- SiLO TFX™ SI Fusion System: A patented, minimally invasive system for sacroiliac joint fusion, designed to treat conditions like sacroiliac joint disruptions and degenerative sacroiliitis
- ZIP product line: Offering Screwless Procedure for MIS Interspinous fusion
CEO Trent Northcutt emphasized the meeting's importance for introducing doctors to new technologies, particularly highlighting DEXA-C's unique bone density matching capability.
Aurora Spine (OTCQB: ASAPF) ha annunciato la sua partecipazione al Meeting Annuale dell'American Academy of Orthopaedic Surgeons (AAOS) 2025, che si terrà dal 10 al 14 marzo 2025, presso il Centro Congressi di San Diego – Stand #1847.
All'incontro più grande al mondo per i professionisti ortopedici, Aurora Spine presenterà la sua linea di prodotti innovativi, tra cui:
- DEXA-C™: una gabbia cervicale per procedure ACDF con tecnologia brevettata DEXA Technology™ che abbina la densità dell'impianto alla densità ossea del paziente
- SiLO TFX™ SI Fusion System: un sistema brevettato e minimamente invasivo per la fusione dell'articolazione sacroiliaca, progettato per trattare condizioni come le disruzioni dell'articolazione sacroiliaca e la sacroiliite degenerativa
- Linea di prodotti ZIP: offre procedure senza viti per la fusione interspinale MIS
Il CEO Trent Northcutt ha sottolineato l'importanza dell'incontro per introdurre i medici a nuove tecnologie, evidenziando in particolare la capacità unica di abbinamento della densità ossea di DEXA-C.
Aurora Spine (OTCQB: ASAPF) ha anunciado su participación en el Reunión Anual de la Academia Americana de Cirujanos Ortopédicos (AAOS) 2025, que se llevará a cabo del 10 al 14 de marzo de 2025, en el Centro de Convenciones de San Diego – Stand #1847.
En la reunión más grande del mundo para profesionales ortopédicos, Aurora Spine exhibirá su innovadora línea de productos, que incluye:
- DEXA-C™: una jaula cervical para procedimientos ACDF con tecnología patentada DEXA Technology™ que iguala la densidad del implante a la densidad ósea del paciente
- SiLO TFX™ SI Fusion System: un sistema patentado y mínimamente invasivo para la fusión de la articulación sacroilíaca, diseñado para tratar condiciones como las disrupciones de la articulación sacroilíaca y la sacroiliitis degenerativa
- Línea de productos ZIP: ofrece procedimientos sin tornillos para la fusión interespinosa MIS
El CEO Trent Northcutt enfatizó la importancia de la reunión para presentar a los médicos nuevas tecnologías, destacando especialmente la capacidad única de coincidencia de densidad ósea de DEXA-C.
오로라 스파인 (OTCQB: ASAPF)은 2025 미국 정형외과 의사 학회(AAOS) 연례 회의에 참여한다고 발표했습니다. 회의는 2025년 3월 10일부터 14일까지 샌디에이고 컨벤션 센터에서 열리며 부스 번호는 #1847입니다.
세계 최대의 정형외과 전문가 모임에서 오로라 스파인은 혁신적인 제품 라인을 선보일 예정입니다. 포함된 제품은 다음과 같습니다:
- DEXA-C™: 환자의 뼈 밀도에 맞춰 임플란트 밀도를 조정하는 특허받은 DEXA 기술이 적용된 경추 케이지입니다.
- SiLO TFX™ SI Fusion System: 천장 관절 융합을 위한 특허받은 최소 침습 시스템으로, 천장 관절 파열 및 퇴행성 천장염과 같은 상태를 치료하도록 설계되었습니다.
- ZIP 제품 라인: MIS 간섭 융합을 위한 나사 없는 절차를 제공합니다.
CEO 트렌트 노스컷은 의사들에게 새로운 기술을 소개하는 회의의 중요성을 강조하며, 특히 DEXA-C의 독특한 뼈 밀도 일치 기능을 강조했습니다.
Aurora Spine (OTCQB: ASAPF) a annoncé sa participation à la Réunion Annuelle de l'American Academy of Orthopaedic Surgeons (AAOS) 2025, qui se tiendra du 10 au 14 mars 2025, au Centre de Convention de San Diego – Stand #1847.
Lors du plus grand rassemblement mondial de professionnels de l'orthopédie, Aurora Spine présentera sa gamme de produits innovants, y compris :
- DEXA-C™: une cage cervicale pour les procédures ACDF utilisant la technologie brevetée DEXA Technology™ qui ajuste la densité de l'implant à celle de l'os du patient
- SiLO TFX™ SI Fusion System: un système breveté et peu invasif pour la fusion de l'articulation sacro-iliaque, conçu pour traiter des conditions telles que les ruptures de l'articulation sacro-iliaque et la sacro-iliite dégénérative
- Ligne de produits ZIP: offrant une procédure sans vis pour la fusion interépineuse MIS
Le PDG Trent Northcutt a souligné l'importance de la réunion pour introduire de nouvelles technologies aux médecins, mettant particulièrement en avant la capacité unique de correspondance de la densité osseuse de DEXA-C.
Aurora Spine (OTCQB: ASAPF) hat seine Teilnahme an der Jahrestagung der American Academy of Orthopaedic Surgeons (AAOS) 2025 vom 10. bis 14. März 2025 im San Diego Convention Center – Stand #1847 bekannt gegeben.
Auf dem weltweit größten Treffen von Orthopädie-Profis wird Aurora Spine seine innovative Produktlinie präsentieren, darunter:
- DEXA-C™: Ein zervikaler Käfig für ACDF-Verfahren mit patentierter DEXA Technology™, die die Implantatdichte an die Knochendichte des Patienten anpasst
- SiLO TFX™ SI Fusion System: Ein patentiertes, minimalinvasives System zur Fusion des Iliosakralgelenks, das zur Behandlung von Zuständen wie Iliosakralgelenksstörungen und degenerativer Sakroiliitis entwickelt wurde
- ZIP Produktlinie: Bietet schraubenfreie Verfahren zur MIS Interspinous Fusion
CEO Trent Northcutt betonte die Bedeutung des Treffens, um Ärzten neue Technologien vorzustellen, und hob insbesondere die einzigartige Fähigkeit von DEXA-C zur Anpassung der Knochendichte hervor.
- None.
- None.
Carlsbad, Calif., March 11, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV:ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that it will be attending the 2025 American Academy of Orthopaedic Surgeons (“AAOS”) Annual Meeting. The meeting will be held at March 10-14, 2025, at the San Diego Convention Center– Booth #1847. AAOS is the world’s largest meeting of orthopaedic surgeons, researchers and allied health professionals.
At this year’s AAOS event, Aurora Spine will be highlighting its product line, including DEXA-C™, a cervical cage for anterior cervical discectomy with fusion (ACDF) procedures. DEXA-C features Aurora's patented DEXA Technology™ that creates a series of implants manufactured with varying densities to match a patient's bone density and DEXA T-Score.
The company will also present its SiLO TFX™ SI Fusion System. The patented, minimally invasive SiLO TFX MIS Sacroiliac Joint Fixation System is intended for sacroiliac joint fusion for conditions including sacroiliac joint disruptions and degenerative sacroiliitis. The SiLO TFX MIS Sacroiliac Joint Fixation System includes a Transfixing-Cone, an ilium screw, a sacrum screw and associated instrumentation. The SiLO TFX implants are designed to transfix the sacrum and ilium, providing stability for bony fusion. The company will also be displaying its line of ZIP products, which offer the Screwless Procedure and enables MIS Interspinous fusion without the use of a screw set.
Mr. Trent Northcutt, Aurora’s President, CEO and co-founder, stated, "We are excited to be attending this year’s AAOS, where many of the country’s top orthopaedic surgeons gather to learn about new products and procedures within the industry. This meeting is a great setting for Aurora to meet up with doctors seeking newer technologies to incorporate into their procedures, like the DEXA-C, which has a proprietary design and technology, and can be used to match with a patient’s bone density, something other cages currently on the market do not consider.”
About Aurora Spine
Aurora Spine is focused on bringing new solutions to the spinal implant market through a series of innovative, minimally invasive, regenerative spinal implant technologies. Additional information can be accessed at www.aurora-spine.com or www.aurorapaincare.com.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains forward-looking information that involves substantial known and unknown risks and uncertainties, most of which are beyond the control of Aurora Spine, including, without limitation, those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Information" in Aurora Spine's final prospectus (collectively, "forward-looking information"). Forward-looking information in this news release includes information concerning the proposed use and success of the company’s products in surgical procedures. Aurora Spine cautions investors of Aurora Spine's securities about important factors that could cause Aurora Spine's actual results to differ materially from those projected in any forward-looking statements included in this news release. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ unilaterally from those expressed in such forward-looking statements. No assurance can be given that the expectations set out herein will prove to be correct and, accordingly, prospective investors should not place undue reliance on these forward-looking statements. These statements speak only as of the date of this press release and Aurora Spine does not assume any obligation to update or revise them to reflect new events or circumstances.
Contact:
Aurora Spine Corporation
Trent Northcutt
President and Chief Executive Officer
(760) 424-2004
Chad Clouse
Chief Financial Officer
(760) 424-2004
FAQ
What products will Aurora Spine (ASAPF) showcase at AAOS 2025?
How does Aurora Spine's DEXA-C technology differ from other cervical cages?
What is the purpose of Aurora Spine's SiLO TFX SI Fusion System?
When and where will Aurora Spine (ASAPF) attend the AAOS 2025 meeting?
What are the key features of Aurora Spine's ZIP product line?
